Skip to main content

Table 1 Patient characteristics at admission and transplantation modalities by group

From: Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections

 EN group (n = 14)PN group (n = 28)p
Age: months, mean (range)131.2 (4.1–251.4)132.4 (10.3–213.1)NS
Sex: M/F, n,4/1016/12NS
Diagnosis of Malignant Disease, n,(%)12 (85.7)23 (82.1)NS
CR at transplant for malignant disease,n, (%)8 (61.5)17 (70.8)NS
Donor, n, (%):  NS
 • Sibling HLA identical1 (7.2)5 (17.9) 
 • MUD7 (50)19 (67.8) 
 • MMUD3 (21.4)1 (3.6) 
 • Haploidentical3 (21.4)3 (10.7) 
Stem cell source, n, (%):  NS
 • BM12 (85.8)26 (92.9) 
 • PBSC1 (7.1)2 (7.1) 
 • CB1 (7.1)0 (0) 
Sex Mismatch, n, (%)7 (50)15 (53.6)NS
Infused stem cell dose, median (x108 MNC/kg)4.714.66NS
Conditioning regimens, n, (%):   
 • MAC13 (92.9)23 (82.1)NS
 • With ATG10 (71.4)20 (71.4)NS
BMI, mean17.5618.76NS
BMI Z-score, mean−0.37−0.06NS
  1. Abbreviations: EN= Enteral Nutrition, PN= Parenteral Nutrition NS= Not statistically Significant, CR= Complete Remission, HLA= Human Leucocyte Antigen, MUD= Matched Unrelated Donor, MMUD= Mismatched Unrelated Donor, BM = Bone Marrow, PBSC= Peripheral Blood Stem Cell, CB= Cord Blood, MNC= Mononuclear Cells, MAC= Myeloablative Condioting, ATG= Anti-Thymocite Globulin, BMI= Body Mass Index
  2. Statistical analysis used to calculate the p value: qualitative variables were compared using Fisher’s exact test, while means were compared with t-test corrected in case of unequal variances. p < 0.05 were considered statistically significant